CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 13 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,915,000 | +5.3% | 1,950,000 | 0.0% | 0.26% | -3.4% |
| Q1 2021 | $1,818,000 | +1.3% | 1,950,000 | 0.0% | 0.26% | -6.4% |
| Q4 2020 | $1,795,000 | 0.0% | 1,950,000 | -0.3% | 0.28% | -14.5% |
| Q3 2020 | $1,795,000 | +2.1% | 1,955,000 | 0.0% | 0.33% | -4.6% |
| Q2 2020 | $1,758,000 | +0.7% | 1,955,000 | -0.3% | 0.35% | -20.1% |
| Q1 2020 | $1,745,000 | +2.3% | 1,960,000 | 0.0% | 0.43% | +30.8% |
| Q4 2019 | $1,705,000 | – | 1,960,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |